Cash Flow Sinomab Bioscience Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-113.00
-200.00
-268.00
-324.00
-342.00
-136.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
2.00
0.00
53.00
-27.00
56.00
-44.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-83.00
-147.00
-156.00
-355.00
-182.00
-162.00
Cash Flow from Investing Activities
-31.00
-59.00
-101.00
-94.00
-165.00
-201.00
Cash Flow from Financing Activities
363.00
85.00
99.00
124.00
74.00
-17.00
Net Cash Inflow / Outflow
234.00
-110.00
-148.00
-255.00
-298.00
-438.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-15.00
11.00
10.00
69.00
-24.00
-57.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sinomab Bioscience Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-113.85868607559
366.019333321449
-479.00
-131.11%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
2.87507145579264
379.430706774908
-377.00
-99.24%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-83.138477076427
563.626964266945
-646.00
-114.75%
Cash Flow from Investing Activities
-31.1713707213852
-536.108510866107
505.00
94.19%
Cash Flow from Financing Activities
363.932422990902
-72.645773449472
435.00
600.97%
Net Cash Inflow / Outflow
234.05641125307
-57.8580074182625
291.00
504.54%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-15.5661639400195
-12.7306873696283
-3.00
-22.27%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 43.82% vs 5.73% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-83.14
-148.00
43.82%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
